pillbase.ru

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

Active substance: HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM

TABLET, FILM COATED · HYDROCHLOROTHIAZIDE 12.5 mg/1, LOSARTAN POTASSIUM 50 mg/1

United StatesActive

Marketing holder: DirectRx

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing hydrochlorothiazide in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
RU 226
  • Амлодипин+Валсартан+Гидрохлоротиазид Канон
    таблетки, покрытые пленочной оболочкой, 5 мг+160 мг+12.5 мг (original in Russian, GRLS)
    ЛП-№(003410)-(РГ-RU)
    Закрытое акционерное общество "Канонфарма продакшн" (ЗАО "Канонфарма продакшн")
  • Амприлан® НД
    таблетки, 25 мг+5 мг (original in Russian, GRLS)
    ЛП-№(002504)-(РГ-RU)
    АО "КРКА, д.д., Ново место"
  • Амприлан® НЛ
    таблетки, 12.5 мг+2.5 мг (original in Russian, GRLS)
    ЛП-№(002509)-(РГ-RU)
    АО "КРКА, д.д., Ново место"
  • Атаканд® Плюс
    таблетки, 16 мг+12.5 мг (original in Russian, GRLS)
    ЛП-№(012425)-(РГ-RU)
    Чеплафарм Арцнаймиттель ГмбХ
  • Атаканд® Плюс
    таблетки, 16 мг+12.5 мг (original in Russian, GRLS)
    ЛСР-001340/08
    Чеплафарм Арцнаймиттель ГмбХ
All products in this country (226)
EU 19
  • Actelsar HCT
    telmisartan, hydrochlorothiazide
    EMEA/H/C/002676
    Actavis Group PTC ehf
  • CoAprovel
    irbesartan, hydrochlorothiazide
    EMEA/H/C/000222
    Sanofi Winthrop Industrie
  • Copalia HCT
    amlodipine, valsartan, hydrochlorothiazide
    EMEA/H/C/001159
    Novartis Europharm Limited
  • Dafiro HCT
    valsartan, hydrochlorothiazide, amlodipine besilate
    EMEA/H/C/001160
    Novartis Europharm Limited
  • Exforge HCT
    valsartan, hydrochlorothiazide, amlodipine besilate
    EMEA/H/C/001068
    Novartis Europharm Limited
All products in this country (19)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2d12-7c74-b0c2-10800df766e6,01a1208c-43d8-7ec5-835a-b5488962a696,01a1208c-4f46-7bfa-a4ad-b995627565d4,01a1208c-5c51-7939-9c14-aba0ee54820e,01a1208c-6828-73f4-b306-2cd081ab4fce;count=169 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
72189-297
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 72189-297 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 72189-297 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 72189-297 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 72189-297 · Verified 2026-10-09 · open in source